Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
August 7, 2009
IN THIS ISSUE
EMEA and FDA collaborate
REACH study
Pfizer Vs. Nigeria
Attacks target Novartis CEO
Funding to reduce animal testing
More...

EMEA and FDA collaborate on good clinical practice
A joint initiative to collaborate on international Good Clinical Practice (GCP) inspection activities has been launched by the EMEA and the FDA. More...

EU issues study on REACH implementation
The Society of Chemical Manufacturers and Affiliates (SOCMA) has reported that Eurostat, the Statistical Office of the European Communities, has published a baseline study or the first snapshot of REACH policy in the preregistration phase. More...

Pfizer Vs. Nigeria's Kano State case comes to a close
An agreement has been reached between Pfizer and Nigeria's Kano State government following the long-running Trovan trial, which stems from the accusation that Pfizer illegally tested the antibiotic Trovan (trovafloxacin) on children in 1996 during a meningitis outbreak. More...

String of attacks aimed at Novartis CEO
Novartis has confirmed that the ashes of CEO Daniel Vasella’s mother have been stolen and his holiday home set fire to. More...

Cash boost for projects to replace, reduce and refine animal testing
Thirteen novel projects that aim to replace, reduce or refine animal testing have received funding totaling £4.5 million (approximately 5.3 million euro) from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs). More...

Are you following us?
Pharmaceutical Technology Europe is on Twitter! More...

Freeze drying centre of excellence unveiled
Reig Jofre has revealed further details about its Barcelona (Spain) based Centre of Excellence in the Freeze Drying Process — a project that represents an investment of approximately 12 million euro. More...

Profile

Complex Documents in the Pharmaceutical Industry Made Easy

Thursday, October 22, 2009
10:00 AM GMT (United Kingdom)

Register Free at www.pharmtech.com/complex
Documents are created just about everywhere in the pharmaceutical industry. To manage interrelated documents, collaboratively created and updated, versioned and published to different targets can often turn into a nightmare. With XML authoring, recurrent tasks such as applying repetitive changes to similar documents or assuring quality for cross-referencing, can finally be automated. During the webinar Ratiopharm, JustSystems and SCHEMA will explain how XML authoring makes document creation and modification more efficient and even safer for pharmaceutical companies. Using cases from different fields (validation documents, clinical study reports and labeling documents) this webcast will outline the potential of this approach to document handling.

Sponsored by: Schema

Key Topic Updates
August events
CPhI South America (Brazil)
EMBO (The Netherlands)
7th World Congress on alternatives and animal use in the life sciences (Italy)
Submit your event
 
White Papers
Custom manufacturing driven by core competencies (Genzyme)
The role of industrial automation in qualified building automation solutions (Rockwell Automation)
Technology approaches to quality management (Sparta Systems)
More White Papers
 
Drug Delivery
Narrowing the gap between clinical capsule formulations and commercial film-coated tablets
Orally disintegrating tablets: the path to improved patient compliance and enhanced life cycle management
Hot-melt extrusion: an emerging drug delivery technology
More drug delivery articles

Key Topic Updates

Survey
Swine flu vaccines are being fast tracked for approval worldwide. Do you think this will compromise their safety and efficacy?
  Yes 49%
  No 51%

This week we would like to know...

When do you read Pharmaceutical Technology Europe?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected]or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.